The increase in price of the brand name drugs most widely used by senior citizens was up 2.9% in 2020.  Although the increase is lower than the last couple of years, it’s still more than double the rate of inflation (currently at 1.3%) and some drugs remain exorbitantly and out of the range of affordability for many seniors.  USA Today recently ran a story on Lynn Carfuto, who has chronic lymphocytic leukemia, a disease which is treatable but with a drug that costs $14K per month.  The drug has seen an 82% price increase since its release in 2013.  She can only afford it due to receiving grants from non-profits.  It’s a very sad case when you have a disease which is treatable but the price is so far out of reach.

 

https://www.pressreader.com/usa/usa-today-us-edition/20210610/282153589220534

Recommended Posts